Scholars@Duke publication: IS CYTOKINE THERAPY SUPERIOR TO CHEMOTHERAPY IN THE MANAGEMENT OF ACUTE MYELOCYTIC-LEUKEMIA EVOLVING FROM MYELODYSPLASIA

IS CYTOKINE THERAPY SUPERIOR TO CHEMOTHERAPY IN THE MANAGEMENT OF ACUTE MYELOCYTIC-LEUKEMIA EVOLVING FROM MYELODYSPLASIA

Publication , Conference

NADEEM, SO; SABA, HI; NAWAB, U; COSGROVE, D; MOSCINSKI, L; SPIERS, ASD; BALDUCCI, L; LYMAN, G; ZUCKERMAN, KS

Published in: BLOOD

1994

BLOOD

0006-4971

1994

A634 / A634

APA

Chicago

ICMJE

MLA

NLM

NADEEM, S. O., SABA, H. I., NAWAB, U., COSGROVE, D., MOSCINSKI, L., SPIERS, A. S. D., … ZUCKERMAN, K. S. (1994). IS CYTOKINE THERAPY SUPERIOR TO CHEMOTHERAPY IN THE MANAGEMENT OF ACUTE MYELOCYTIC-LEUKEMIA EVOLVING FROM MYELODYSPLASIA. In BLOOD (Vol. 84, pp. A634–A634).

NADEEM, S. O., H. I. SABA, U. NAWAB, D. COSGROVE, L. MOSCINSKI, A. S. D. SPIERS, L. BALDUCCI, G. LYMAN, and K. S. ZUCKERMAN. “IS CYTOKINE THERAPY SUPERIOR TO CHEMOTHERAPY IN THE MANAGEMENT OF ACUTE MYELOCYTIC-LEUKEMIA EVOLVING FROM MYELODYSPLASIA.” In BLOOD, 84:A634–A634, 1994.

NADEEM SO, SABA HI, NAWAB U, COSGROVE D, MOSCINSKI L, SPIERS ASD, BALDUCCI L, LYMAN G, ZUCKERMAN KS. IS CYTOKINE THERAPY SUPERIOR TO CHEMOTHERAPY IN THE MANAGEMENT OF ACUTE MYELOCYTIC-LEUKEMIA EVOLVING FROM MYELODYSPLASIA. BLOOD. 1994. p. A634–A634.

BLOOD

0006-4971

1994

A634 / A634